Veritas Genetics
Best clinician-style preventive WGS, with the highest access friction. Veritas is the only consumer WGS in 2026 that treats whole-genome reading as a preventive-medicine intervention rather than a consumer product — pre- and post-test counselor sessions are both included and both substantive, and the report is formatted for a physician to act on. The prescription gate is a real barrier that hands the casual market to competitors; the counselor-mediated structure is why the people who use it get more value than any other category. Clinical-grade WGS pioneer; survived a 2019 US operational pause. Our review covers all eight dimensions we test — from coverage depthcoverageHow many times, on average, each base is read. 30× is the consumer standard; 100× is used for hard-to-call variants and some cancer assays; 1× (low-pass) is suitable for genealogy but not for clinical variant calls. to clinical reporting quality — based on kits purchased with reader-supported funds, timed turnarounds across six orders, and an independent check of raw read filesFASTQRaw sequencing read file. The unprocessed output of the sequencer..
- ＋Pre- AND post-test genetic counselor sessions — substantive, not a five-minute upsell
- ＋CLIA-certified quality: closest thing to a clinical WGS in the consumer space
- ＋Preventive-medicine framing explicitly targeted at healthy adults, not just existing patients
- ＋Back to stable operations in the US after 2019 turbulence
- —Prescription required — Veritas provides one via telegenetics, but the extra step will turn away casual buyers
- —Premium price — nearly $100 more than most 30× peers
- —Up to 16 weeks from kit receipt to report
Pricing & coverage tiers
| Tier | Coverage | Price | Best for |
|---|---|---|---|
| myGenome | 30× | $599 | Consumer standard |
- Clinician-reviewed clinical report
- Pre-test AND post-test genetic counselor consultation (both included)
- Pharmacogenomics
- Carrier status
- Prescription-gated preventive findings
HIPAA-aligned, clinical-grade storage
The Veritas dossier, based on public information.
Template narrative · pending independent testing
Veritas Genetics sits in the consumer whole genome sequencingWGSWhole Genome Sequencing — reading (nearly) all 3 billion base pairs of your DNA, as opposed to genotyping arrays which sample ~600,000 known positions. market at a price point of $599. Sequencing runs on short-read (illumina), clia-certified laboratory. Company's public turnaround claim: 12–16 weeks. This section renders a structured summary from public information until our reader-supported testing cycle publishes.
Raw files — BAMBAMAligned reads mapped to a reference genome. The typical intermediate file., FASTQFASTQRaw sequencing read file. The unprocessed output of the sequencer., VCFVCFVariant Call Format — the compact list of positions where your genome differs from the reference. — are available to customers. Best clinician-style preventive WGS, with the highest access friction. Our editorial verdict at a glance: Best clinician-style preventive WGS, with the highest access friction. Veritas is the only consumer WGS in 2026 that treats whole-genome reading as a preventive-medicine intervention rather than a consumer product — pre- and post-test counselor sessions are both included and both substantive, and the report is formatted for a physician to act on. The prescription gate is a real barrier that hands the casual market to competitors; the counselor-mediated structure is why the people who use it get more value than any other category.
The documented weak spots are prescription required — veritas provides one via telegenetics, but the extra step will turn away casual buyers, and up to 16 weeks from kit receipt to report. Neither is necessarily a deal-breaker, but both are worth weighing before you click buy.
Editors can replace this template with a full narrative in the Payload admin: Collections → Companies → Veritas Genetics → Full review (company detail page).